Altman Peter 的 Form 4/A 修正申報
修正BioCardia, Inc.（BCDA），2023/4/14 申報
- 申報編號
- 0001437749-23-010355
- 申報時間
- 2023/4/14
- 交易日
- 2022/5/13
- 申報延遲
- 336 天
- 10b5-1 計畫
- 沒有勾選
- 原始申報日
- 2022/5/13
這份申報列了 1 筆非衍生性交易。沿用原件裡沒有重述的 3 筆交易。公開市場買進合計 $1.86 萬。交易後 336 天申報。
這份修正申報重述了 0001437749-22-012420（2022/5/13 申報）的一部分，沒有重述的交易仍然有效，列在下面。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Altman PeterCIK 0001647542 | 董事、高階主管（總裁、執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/5/13 | Common Stock | A公司授予處分 | −3,498 | $1.37F2 | −$4,792.26 | 348,943 | 直接 |
沿用原件的交易
這份修正申報只重述了原件的一部分。原件其他的交易仍然有效，網站的交易表把它們算在這份修正申報底下。
來自 0001437749-22-012420（2022/5/13 申報）。
非衍生性證券（表 I）
原件的附註
這幾筆交易的價格在原件上引用的附註。
- F1
This transaction was executed in multiple trades ranging from $1.29 to $1.30 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
This transaction was executed in multiple trades ranging from $1.13 to $1.40 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades ranging from $1.32 to $1.45 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The original Form 4 filed on May 13, 2022 incorrectly reported that 2,698 shares were purchased. 3,498 shares were purchased on May 13, 2022 and are correctly reported herein.
- F2
This transaction was executed in multiple trades ranging from $1.32 to $1.45 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The original Form 4 incorrectly reported that 348,143 shares were beneficially owned following the reported transaction. The corrected amount is reported herein.